vs
Side-by-side financial comparison of FONAR CORP (FONR) and First Western Financial Inc (MYFW). Click either name above to swap in a different company.
First Western Financial Inc is the larger business by last-quarter revenue ($27.5M vs $25.5M, roughly 1.1× FONAR CORP). Over the past eight quarters, First Western Financial Inc's revenue compounded faster (10.0% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.
FONR vs MYFW — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $27.5M |
| Net Profit | $2.1M | — |
| Gross Margin | — | — |
| Operating Margin | 13.5% | — |
| Net Margin | 8.0% | — |
| Revenue YoY | 2.4% | — |
| Net Profit YoY | 4.7% | — |
| EPS (diluted) | — | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $27.5M | ||
| Q4 25 | $25.5M | $26.7M | ||
| Q3 25 | $26.0M | $26.3M | ||
| Q2 25 | $27.3M | $24.2M | ||
| Q1 25 | $27.2M | $24.8M | ||
| Q4 24 | $24.9M | $24.3M | ||
| Q3 24 | $25.0M | $22.5M | ||
| Q2 24 | $25.9M | $22.8M |
| Q1 26 | — | — | ||
| Q4 25 | $2.1M | $3.3M | ||
| Q3 25 | $2.3M | $3.2M | ||
| Q2 25 | $729.3K | $2.5M | ||
| Q1 25 | $2.5M | $4.2M | ||
| Q4 24 | $2.0M | $2.7M | ||
| Q3 24 | $3.1M | $2.1M | ||
| Q2 24 | $830.4K | $1.1M |
| Q1 26 | — | — | ||
| Q4 25 | 13.5% | 16.6% | ||
| Q3 25 | 14.1% | 15.1% | ||
| Q2 25 | 5.3% | 13.7% | ||
| Q1 25 | 15.2% | 21.6% | ||
| Q4 24 | 11.9% | 16.1% | ||
| Q3 24 | 21.0% | 11.9% | ||
| Q2 24 | 7.4% | 6.2% |
| Q1 26 | — | — | ||
| Q4 25 | 8.0% | 12.9% | ||
| Q3 25 | 8.7% | 12.1% | ||
| Q2 25 | 2.7% | 10.3% | ||
| Q1 25 | 9.2% | 16.9% | ||
| Q4 24 | 7.9% | 11.3% | ||
| Q3 24 | 12.6% | 9.5% | ||
| Q2 24 | 3.2% | 4.7% |
| Q1 26 | — | $0.63 | ||
| Q4 25 | — | $0.33 | ||
| Q3 25 | — | $0.32 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.43 | ||
| Q4 24 | — | $0.28 | ||
| Q3 24 | — | $0.22 | ||
| Q2 24 | — | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $121.0K | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $176.9M | $273.4M |
| Total Assets | $217.2M | $3.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $121.0K | — | ||
| Q3 25 | $122.0K | — | ||
| Q2 25 | $56.5M | — | ||
| Q1 25 | $123.0K | — | ||
| Q4 24 | $121.0K | — | ||
| Q3 24 | $136.0K | — | ||
| Q2 24 | $56.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.9K | — |
| Q1 26 | — | $273.4M | ||
| Q4 25 | $176.9M | $265.6M | ||
| Q3 25 | $174.9M | $261.5M | ||
| Q2 25 | $172.6M | $258.8M | ||
| Q1 25 | $171.9M | $256.6M | ||
| Q4 24 | $169.8M | $252.3M | ||
| Q3 24 | $168.7M | $248.8M | ||
| Q2 24 | $166.0M | $246.9M |
| Q1 26 | — | $3.2B | ||
| Q4 25 | $217.2M | $3.2B | ||
| Q3 25 | $218.4M | $3.2B | ||
| Q2 25 | $216.9M | $3.0B | ||
| Q1 25 | $214.9M | $2.9B | ||
| Q4 24 | $208.0M | $2.9B | ||
| Q3 24 | $212.3M | $2.9B | ||
| Q2 24 | $214.2M | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $171.0K | — |
| Free Cash FlowOCF − Capex | $-227.0K | — |
| FCF MarginFCF / Revenue | -0.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | 0.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $171.0K | $-1.8M | ||
| Q3 25 | $1.7M | $10.0M | ||
| Q2 25 | $4.2M | $-9.1M | ||
| Q1 25 | $3.1M | $8.0M | ||
| Q4 24 | $2.2M | $606.0K | ||
| Q3 24 | $1.7M | $18.8M | ||
| Q2 24 | $4.6M | $-11.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-227.0K | $-5.8M | ||
| Q3 25 | $-177.0K | $9.0M | ||
| Q2 25 | $3.6M | $-9.7M | ||
| Q1 25 | $2.6M | $7.0M | ||
| Q4 24 | $1.5M | $-607.0K | ||
| Q3 24 | $-148.0K | $18.6M | ||
| Q2 24 | $4.2M | $-11.9M |
| Q1 26 | — | — | ||
| Q4 25 | -0.9% | -21.6% | ||
| Q3 25 | -0.7% | 34.1% | ||
| Q2 25 | 13.1% | -39.9% | ||
| Q1 25 | 9.4% | 28.1% | ||
| Q4 24 | 6.0% | -2.5% | ||
| Q3 24 | -0.6% | 82.3% | ||
| Q2 24 | 16.1% | -52.1% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 14.9% | ||
| Q3 25 | 7.2% | 4.1% | ||
| Q2 25 | 2.4% | 2.4% | ||
| Q1 25 | 2.2% | 4.2% | ||
| Q4 24 | 3.0% | 5.0% | ||
| Q3 24 | 7.2% | 1.3% | ||
| Q2 24 | 1.6% | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | -0.54× | ||
| Q3 25 | 0.75× | 3.15× | ||
| Q2 25 | 5.79× | -3.63× | ||
| Q1 25 | 1.26× | 1.91× | ||
| Q4 24 | 1.14× | 0.22× | ||
| Q3 24 | 0.53× | 8.83× | ||
| Q2 24 | 5.54× | -10.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
MYFW
| Net Interest Income | $20.9M | 76% |
| Noninterest Income | $6.7M | 24% |
